Ovarian Cancer at Johns Hopkins What's New? Resources Ovarian Cancer Community Coping with Ovarian Cancer Clinical Trials
 

You Should Know

Anatomy

Prevention

Risk Factors

Genetics

Screening

CA 125

Symptoms

Early Detection

Diagnosis

Radiology

Pathologists

Staging

Treatment

Recurrent Disease

Recurrent Q & A

Nutrition

Prognosis

Clinical Trials

Glossary

Discussion Board

Questions for Dr.




Diagnosis: Types of Tumors

Epithelial Cancer: Endometrioid carcinoma
These tumors are most common in the fifth and sixth decades, and the mean patient age is 56 years. The most common symptoms are abdominal distention and pelvic or abdominal pain. Abnormal vaginal bleeding is also frequent. Most patients have an adnexal mass on pelvic examination. It has often been stated that endometrioid carcinomas of the ovary have a better prognosis than typical serous carcinomas of the ovary. However, this is largely if not completely due to the high proportion of cases presenting in stage I. When stratified by stage, all subtypes of ovarian carcinoma have a similar prognosis. The apparent favorable prognosis may also be due, in part, to a high proportion of grade I cases, although data on the influence of grade on prognosis are less clear. Treatment for endometrioid carcinoma is generally the same as that for other ovarian carcinomas. However, progestational agents, antiestrogens, tamoxifen, and other hormonal therapies have been used with limited success in previously treated endometrioid carcinomas; 10-15% response rates have been reported. There may be a correlation between the presence of steroid hormone receptors in tumor tissue and response rates, but data are limited. Hormonal therapy may be a viable option for treatment of recurrence in patients who have failed or cannot tolerate chemotherapy or surgery.

  
     
HONcode Logo We subscribe to the HONcode principles. Verify

Copyright © 2000-2019 Johns Hopkins University.
All rights reserved.
Disclaimer & Privacy   Last modified April 23, 2001